Stay updated with breaking news from Biosolutions Inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Shares of Emergent BioSolutions Inc. (NYSE:EBS – Get Rating) have received a consensus recommendation of “Hold” from the seven brokerages that are currently covering the company, Marketbeat Ratings reports. Two analysts have rated the stock with a sell recommendation, one has assigned a hold recommendation and two have given a buy recommendation to the company. […]
Prescott Group Capital Management L.L.C. purchased a new position in Emergent BioSolutions Inc. (NYSE:EBS – Get Rating) during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 91,000 shares of the biopharmaceutical company’s stock, valued at approximately $1,075,000. Prescott Group Capital Management L.L.C. […]
StockNews.com initiated coverage on shares of Emergent BioSolutions (NYSE:EBS – Get Rating) in a report released on Thursday morning. The firm issued a sell rating on the biopharmaceutical company’s stock. Other equities research analysts have also recently issued reports about the company. Benchmark upgraded Emergent BioSolutions from a hold rating to a buy rating and […]
Emergent BioSolutions (NYSE:EBS – Get Rating) announced its earnings results on Tuesday. The biopharmaceutical company reported ($3.17) EPS for the quarter, missing the consensus estimate of ($1.67) by ($1.50), Briefing.com reports. Emergent BioSolutions had a negative net margin of 19.97% and a negative return on equity of 7.57%. The firm had revenue of $165.10 million […]
Emergent BioSolutions (NYSE:EBS – Get Rating) issued its quarterly earnings data on Tuesday. The biopharmaceutical company reported ($3.17) EPS for the quarter, missing the consensus estimate of ($1.67) by ($1.50), Briefing.com reports. The business had revenue of $165.10 million during the quarter, compared to analyst estimates of $142.85 million. Emergent BioSolutions had a negative net […]